BSEBeryl Drugs LtdLowPositive
Announced Mon, 29 Jun · 13:02 IST

Promoter Sudhir Sethi buys 6,950 shares, holding crosses 10 percent

Promoter Stake BuyCreeping Acquisition Near ThresholdOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.5%1-day move
₹23.50
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.5-10.6-2.5-9.8-11.9+0.7-5.5
Up moveDown movePending
AI summary

Promoter Sudhir Sethi acquired 6,950 shares (0.14%) of Beryl Drugs on June 25, 2026 via open-market transactions. His holding rose from 9.915% to 10.055%, crossing the 10% substantial shareholder threshold. The disclosure was filed under SEBI SAST Regulation 29(2). Total equity capital of the company stands at 50.71 lakh shares, which remains unchanged.

Likely market impact

Signals promoter confidence via open-market buying. Crossing 10 percent threshold triggers extra SEBI disclosure norms going forward.